Ep 21: Andy Coravos and Ashoka Rajendra on Hyperspecialization in Pharma R&D and Digital Biomarkers

episode

Vital Signs with Jacob Effron and Nikhil Krishnan not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

Booked out doesn't mean you're ready for an associate OD 23 min · 23 Sep 2026 · The Optometry Success Podcast

Could sofa theory help you find your ideal partner? 4 min · 23 Sep 2026 · Do you really know?

Behind The Scenes At Vogue World Milano 28 min · 23 Sep 2026 · The Run-Through with Vogue

Is end-to-end encryption really secure? 4 min · 23 Sep 2026 · Do you really know?

Do tongue scrapers actually help with bad breath? 5 min · 23 Sep 2026 · Do you really know?

Lab Notes: Have we found dark matter? 10 min · 23 Sep 2026 · The Science Show

Report any issue

Source

Recorded25 Apr 2023

Publisherfeeds.simplecast.com ↗

Handlerec:14381002

Show notes

Jacob sits down with HumanFirst CEO Andy Coravos and Orchestra CEO Ashoka Rajendra to discuss at home data collection in trials, Andy being an EIR at the FDA, why Benchling has been so successful and more.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related